MARKET OPEN: Covid drug trial sets upbeat tone for local trading

MARKET OPEN: Covid drug trial sets upbeat tone for local trading
Paul McBeth
New Zealand’s stock market may be in for a positive start to the week after Wall Street closed stronger on Friday on optimism over a late-stage trial of the Remdesivir drug in treating covid-19. Investor optimism over the economic recovery from the covid-19 pandemic was stoked by drug company Gilead’s news that its antiviral remdesivir product significantly aided the recovery of severely ill patients. Australia’s Therapeutics Goods Administration gave provisional approval for remdesivir to be used in adults with severe covid symptoms. “Gi...

More Markets

Air NZ backs mission-critical startup OneReg
Markets

Air NZ backs mission-critical startup OneReg

Airline's support boosts regulatory compliance startup's global ambitions.

Hidden gems for investors outside tech darlings
Markets

Hidden gems for investors outside tech darlings

AI may be getting all the attention but leaves opportunity for investors, experts say.

NZ sharemarket dips as big stocks weigh despite KMD gains
Markets

NZ sharemarket dips as big stocks weigh despite KMD gains

The NZ sharemarket closed down, although KMD Brands lifted on a positive result.

Tom Raynel 19 Nov 2025